CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

NCT03726398 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Did not identify eligible candidates

Conditions

Interstitial Lung Disease
Scleroderma
Pulmonary Hypertension

Interventions

DRUG: Opsumit 10 Mg Tablet

Sponsor

Franz Rischard, DO

Collaborators

[object Object]
[object Object]